NCT03615534View on ClinicalTrials.gov

Extended Release Niacin and Fenofibrate for the Treatment of Atherogenic Dyslipidemia in Obese Females

PHASE4CompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

October 1, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

October 30, 2015

Conditions
Atherogenic DyslipidemiaObesity Associated Disorder
Interventions
OTHER

Therapeutic Lifestyle Changes

Four-week therapeutic lifestyle changes run-in period, comprising individualized moderate physical activity and total calories reduction.

OTHER

Placebo

DRUG

Fenofibrate

DIETARY_SUPPLEMENT

Wax Matrix Extended Release Niacin (WMER Niacin)

Trial Locations (2)

10045

Al Kindy College of Medicine, University of Baghdad, Baghdad

Lewai S Abdulaziz, Baghdad

All Listed Sponsors
collaborator

Al-Kindy College of Medicine

OTHER

lead

Lewai Sharki Abdulaziz, MSc PhD

OTHER

NCT03615534 - Extended Release Niacin and Fenofibrate for the Treatment of Atherogenic Dyslipidemia in Obese Females | Biotech Hunter | Biotech Hunter